Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Adult congenital heart disease guideline gets 10-year update, new classification system

    August 16, 2018

    New data in the expanding range of adults with congenital heart disease spurred a revamp of the guidelines.

  • 1
    News

    Larger vegetation size associated with increased risk of embolism and mortality in infective endocarditis

    August 10, 2018

    In patients with infective endocarditis, does a vegetation size greater than 10 mm impart a greater embolic risk?

  • 1
    News

    Catheter ablation of AF in patients with heart failure decreases mortality and HF admissions

    August 7, 2018

    How does ablation of atrial fibrillation (AF) compare with medical therapy for patients with heart failure with reduced left ventricular ejection fraction (LVEF)?

  • News

    Ten tips for managing patients with both heart failure and COPD

    July 26, 2018

    Diagnose them early, treat them early, and build a team of experts and support services with the patients.

  • 1
    News

    Epinephrine for cardiac arrest: Better survival, more brain damage

    July 19, 2018

    PARAMEDIC2 clears uncertainties in treating out-of-hospital cardiac arrest.

  • 1
    News

    New hypertension guidelines would add 15.6 million new diagnoses

    July 11, 2018

    A new analysis estimates that adopting the 2017 ACC/AHA hypertension guidelines would add 15 million Americans to the ranks of the hypertensives, and half of those would be candidates for treatment.Similar increases would occur in other countries, according to study auth...

  • 1
    News

    Rebleeding and mortality after lower-GI bleeding in patients taking antiplatelets or anticoagulants

    July 11, 2018

    Clinical question: Is there a difference in lower GI rebleeding risk in patients on antiplatelet medications versus those on anticoagulation medications?

  • 1
    News

    Alteplase, aspirin provide similar functional outcomes after nondisabling stroke

    July 10, 2018

    PRISMS trial results suggest that alteplase offers no benefit over aspirin for functional outcomes after nondisabling acute ischemic stroke.

  • 1
    News

    DOACs’ safety affirmed in real-world setting

    July 9, 2018

    Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.

  • 1
    News

    New look at ATLAS suggests rivaroxaban may still have role in ACS

    July 2, 2018

    A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.

Previous1 … 56 57 58 59 60 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences